申请人:Optikira LLC
公开号:US20200354367A1
公开(公告)日:2020-11-12
The present invention provides novel compounds, compositions and methods for treating or preventing an IRE1α-related disease or disorder. In certain embodiments, the disease or disorder is selected from the group consisting of a neurodegenerative disease, a demyelinating disease, cancer, an eye disease, a fibrotic disease, and diabetes.